Our Business

Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.

Working in Partnership

With the health and wellbeing of patients at the centre of everything we do, Takeda UK enthusiastically embraces opportunities to work collaboratively in new ways with healthcare providers to help fulfil the requirements of the evolving NHS.


Research & Development

We aspire to be a dynamic R&D organization that thinks, acts and interacts with the external world like no other. We will achieve this through an intense focus on the best science for those therapies that can deliver true innovation for patients. 

Learn more

Our Products

Takeda seeks to improve people's lives by researching, developing and bringing to market new and better medicines that help to address the nation's most pressing healthcare needs. We focus on the areas of oncology, gastroenterology and diabetes.


Therapeutic Areas


To innovate with the great impact, we will focus on our 3 therapeutic areas - oncology, gastroenterology (GI), and central nervous system (CNS) disease areas. Moreover, we intend to continue to build upon our global health approach to Vaccines. 


Access to Medicines


Through our Access to Medicines strategy, we are expanding on our existing commitments to enhance global health so that eligible patients in evolving healthcare systems can have access to our innovative and potentially life-saving medicines, even if their ability to pay for the full cost of treatment is limited



Date Of Preparation: December 2017